Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients.

Standing JF, Buggiotti L, Guerra-Assuncao JA, Woodall M, Ellis S, Agyeman AA, Miller C, Okechukwu M, Kirkpatrick E, Jacobs AI, Williams CA, Roy S, Martin-Bernal LM, Williams R, Smith CM, Sanderson T, Ashford FB, Emmanuel B, Afzal ZM, Shields A, Richter AG, Dorward J, Gbinigie O, Van Hecke O, Lown M, Francis N, Jani B, Richards DB, Rahman NM, Yu LM, Thomas NPB, Hart ND, Evans P, Andersson M, Hayward G, Hood K, Nguyen-Van-Tam JS, Little P, Hobbs FDR, Khoo S, Butler C, Lowe DM, Breuer J, PANORAMIC Virology Group

Open source

DOI: 10.1038/s41467-024-45641-0
Published: 2024 Feb 23
Container: Nature communications
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41467-024-45641-0,
  title = {Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients.},
  author = {Standing JF and Buggiotti L and Guerra-Assuncao JA and Woodall M and Ellis S and Agyeman AA and Miller C and Okechukwu M and Kirkpatrick E and Jacobs AI and Williams CA and Roy S and Martin-Bernal LM and Williams R and Smith CM and Sanderson T and Ashford FB and Emmanuel B and Afzal ZM and Shields A and Richter AG and Dorward J and Gbinigie O and Van Hecke O and Lown M and Francis N and Jani B and Richards DB and Rahman NM and Yu LM and Thomas NPB and Hart ND and Evans P and Andersson M and Hayward G and Hood K and Nguyen-Van-Tam JS and Little P and Hobbs FDR and Khoo S and Butler C and Lowe DM and Breuer J and PANORAMIC Virology Group},
  year = {2024},
  journal = {Nature communications},
  doi = {10.1038/s41467-024-45641-0},
  url = {https://doi.org/10.1038/s41467-024-45641-0}
}

RIS

TY  - JOUR
TI  - Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients.
AU  - Standing JF
AU  - Buggiotti L
AU  - Guerra-Assuncao JA
AU  - Woodall M
AU  - Ellis S
AU  - Agyeman AA
AU  - Miller C
AU  - Okechukwu M
AU  - Kirkpatrick E
AU  - Jacobs AI
AU  - Williams CA
AU  - Roy S
AU  - Martin-Bernal LM
AU  - Williams R
AU  - Smith CM
AU  - Sanderson T
AU  - Ashford FB
AU  - Emmanuel B
AU  - Afzal ZM
AU  - Shields A
AU  - Richter AG
AU  - Dorward J
AU  - Gbinigie O
AU  - Van Hecke O
AU  - Lown M
AU  - Francis N
AU  - Jani B
AU  - Richards DB
AU  - Rahman NM
AU  - Yu LM
AU  - Thomas NPB
AU  - Hart ND
AU  - Evans P
AU  - Andersson M
AU  - Hayward G
AU  - Hood K
AU  - Nguyen-Van-Tam JS
AU  - Little P
AU  - Hobbs FDR
AU  - Khoo S
AU  - Butler C
AU  - Lowe DM
AU  - Breuer J
AU  - PANORAMIC Virology Group
PY  - 2024
JO  - Nature communications
DO  - 10.1038/s41467-024-45641-0
UR  - https://doi.org/10.1038/s41467-024-45641-0
ER  -

APA

JF, S., L, B., JA, G., M, W., S, E., AA, A., C, M., M, O., E, K., AI, J., CA, W., S, R., LM, M., R, W., CM, S., T, S., FB, A., B, E., ZM, A., A, S., AG, R., J, D., O, G., O, V. H., M, L., N, F., B, J., DB, R., NM, R., LM, Y., NPB, T., ND, H., P, E., M, A., G, H., K, H., JS, N., P, L., FDR, H., S, K., C, B., DM, L., J, B., & Group, P. V. (2024). Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients.. Nature communications. https://doi.org/10.1038/s41467-024-45641-0

Source records

pubmed · retrieved 2026-09-26T04:15:25.535Z